Eisai Co., Ltd. (4523.T)
JPY 4338.0
(-0.28%)
JPY 4338.0
(-0.28%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 741.75 Billion JPY | -0.36% |
| 2022 | 744.4 Billion JPY | -1.56% |
| 2021 | 756.22 Billion JPY | 17.07% |
| 2020 | 645.94 Billion JPY | -7.14% |
| 2019 | 695.62 Billion JPY | 8.21% |
| 2018 | 642.83 Billion JPY | 7.13% |
| 2017 | 600.05 Billion JPY | 11.31% |
| 2016 | 539.09 Billion JPY | -1.61% |
| 2015 | 547.92 Billion JPY | -0.1% |
| 2014 | 548.46 Billion JPY | -8.64% |
| 2013 | 600.35 Billion JPY | 4.65% |
| 2012 | 573.67 Billion JPY | -11.46% |
| 2011 | 647.92 Billion JPY | -15.74% |
| 2010 | 768.92 Billion JPY | -4.26% |
| 2009 | 803.13 Billion JPY | 2.74% |
| 2008 | 781.7 Billion JPY | 6.44% |
| 2007 | 734.41 Billion JPY | 8.94% |
| 2006 | 674.17 Billion JPY | 12.13% |
| 2005 | 601.25 Billion JPY | 12.78% |
| 2004 | 533.13 Billion JPY | 6.6% |
| 2003 | 500.12 Billion JPY | 7.18% |
| 2002 | 466.61 Billion JPY | 8.08% |
| 2001 | 431.74 Billion JPY | 19.36% |
| 2000 | 361.71 Billion JPY | 19.59% |
| 1999 | 302.47 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 189.02 Billion JPY | -0.77% |
| 2023 Q2 | 176.61 Billion JPY | -10.32% |
| 2023 FY | 741.75 Billion JPY | -0.36% |
| 2023 Q4 | 190.49 Billion JPY | 7.2% |
| 2023 Q3 | 177.7 Billion JPY | 0.61% |
| 2023 Q1 | 196.93 Billion JPY | -0.64% |
| 2022 FY | 744.4 Billion JPY | -1.56% |
| 2022 Q2 | 174.36 Billion JPY | -5.37% |
| 2022 Q3 | 187.57 Billion JPY | 7.57% |
| 2022 Q4 | 198.2 Billion JPY | 5.67% |
| 2022 Q1 | 184.26 Billion JPY | -3.48% |
| 2021 FY | 756.22 Billion JPY | 17.07% |
| 2021 Q2 | 163.45 Billion JPY | -17.82% |
| 2021 Q1 | 198.89 Billion JPY | 34.74% |
| 2021 Q3 | 202.97 Billion JPY | 24.17% |
| 2021 Q4 | 190.9 Billion JPY | -5.95% |
| 2020 Q1 | 165.58 Billion JPY | -20.98% |
| 2020 FY | 645.94 Billion JPY | -7.14% |
| 2020 Q2 | 151.46 Billion JPY | -8.53% |
| 2020 Q4 | 147.61 Billion JPY | -18.58% |
| 2020 Q3 | 181.28 Billion JPY | 19.69% |
| 2019 Q3 | 186.8 Billion JPY | 28.59% |
| 2019 FY | 695.62 Billion JPY | 8.21% |
| 2019 Q1 | 154 Billion JPY | -12.29% |
| 2019 Q4 | 209.55 Billion JPY | 12.18% |
| 2019 Q2 | 145.26 Billion JPY | -5.67% |
| 2018 Q4 | 175.58 Billion JPY | 11.74% |
| 2018 Q2 | 156.82 Billion JPY | 2.29% |
| 2018 Q1 | 153.3 Billion JPY | -4.25% |
| 2018 Q3 | 157.12 Billion JPY | 0.2% |
| 2018 FY | 642.83 Billion JPY | 7.13% |
| 2017 FY | 600.05 Billion JPY | 11.31% |
| 2017 Q3 | 154.86 Billion JPY | 8.14% |
| 2017 Q2 | 143.21 Billion JPY | 0.96% |
| 2017 Q1 | 141.85 Billion JPY | 9.23% |
| 2017 Q4 | 160.11 Billion JPY | 3.39% |
| 2016 Q2 | 132.96 Billion JPY | -2.89% |
| 2016 FY | 539.09 Billion JPY | -1.61% |
| 2016 Q3 | 139.32 Billion JPY | 4.79% |
| 2016 Q1 | 136.92 Billion JPY | 12.72% |
| 2016 Q4 | 129.87 Billion JPY | -6.79% |
| 2015 Q1 | 139.24 Billion JPY | -0.53% |
| 2015 Q2 | 136.25 Billion JPY | -2.15% |
| 2015 Q4 | 121.47 Billion JPY | -19.53% |
| 2015 Q3 | 150.94 Billion JPY | 10.78% |
| 2015 FY | 547.92 Billion JPY | -0.1% |
| 2014 Q1 | 132.82 Billion JPY | -12.81% |
| 2014 Q4 | 139.98 Billion JPY | 0.4% |
| 2014 Q2 | 136.22 Billion JPY | 2.56% |
| 2014 Q3 | 139.42 Billion JPY | 2.35% |
| 2014 FY | 548.46 Billion JPY | -8.64% |
| 2013 Q2 | 151.6 Billion JPY | -1.69% |
| 2013 FY | 600.35 Billion JPY | 4.65% |
| 2013 Q4 | 152.34 Billion JPY | 8.29% |
| 2013 Q3 | 140.68 Billion JPY | -7.21% |
| 2013 Q1 | 154.21 Billion JPY | 8.51% |
| 2012 Q3 | 143.11 Billion JPY | 1.13% |
| 2012 Q4 | 142.11 Billion JPY | -0.7% |
| 2012 Q1 | 146.91 Billion JPY | 2.58% |
| 2012 FY | 573.67 Billion JPY | -11.46% |
| 2012 Q2 | 141.52 Billion JPY | -3.67% |
| 2011 Q4 | 143.22 Billion JPY | -17.57% |
| 2011 Q2 | 163.69 Billion JPY | -2.12% |
| 2011 FY | 647.92 Billion JPY | -15.74% |
| 2011 Q1 | 167.25 Billion JPY | 7.85% |
| 2011 Q3 | 173.75 Billion JPY | 6.14% |
| 2010 Q1 | 204.49 Billion JPY | 2.91% |
| 2010 Q4 | 155.08 Billion JPY | -23.05% |
| 2010 FY | 768.92 Billion JPY | -4.26% |
| 2010 Q3 | 201.54 Billion JPY | -3.01% |
| 2010 Q2 | 207.8 Billion JPY | 1.62% |
| 2009 Q3 | 209.49 Billion JPY | 4.59% |
| 2009 Q4 | 198.71 Billion JPY | -5.15% |
| 2009 FY | 803.13 Billion JPY | 2.74% |
| 2009 Q1 | 194.61 Billion JPY | 6.32% |
| 2009 Q2 | 200.31 Billion JPY | 2.92% |
| 2008 Q3 | 199.82 Billion JPY | -1.57% |
| 2008 FY | 781.7 Billion JPY | 6.44% |
| 2008 Q1 | 195.81 Billion JPY | 0.0% |
| 2008 Q2 | 203.01 Billion JPY | 3.68% |
| 2008 Q4 | 183.05 Billion JPY | -8.39% |
| 2007 FY | 734.41 Billion JPY | 8.94% |
| 2006 FY | 674.17 Billion JPY | 12.13% |
| 2005 FY | 601.25 Billion JPY | 12.78% |
| 2004 FY | 533.13 Billion JPY | 6.6% |
| 2003 FY | 500.12 Billion JPY | 7.18% |
| 2002 FY | 466.61 Billion JPY | 8.08% |
| 2001 FY | 431.74 Billion JPY | 19.36% |
| 2000 FY | 361.71 Billion JPY | 19.59% |
| 1999 FY | 302.47 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -1093.543% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 82.603% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | -135.807% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | -70.486% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -9485.296% |
| Nippon Shinyaku Co., Ltd. | 148.25 Billion JPY | -400.321% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -929.581% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -5878.97% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | -423.444% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | -620.952% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -1238.756% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -2312.355% |
| Tsumura & Co. | 150.84 Billion JPY | -391.731% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -881.425% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -1257.573% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | -225.424% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -1714.06% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | -879.532% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | -520.546% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -14617.282% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -1481.727% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -13169.942% |
| MedRx Co., Ltd | 26 Million JPY | -2852788.462% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -6649.489% |
| Solasia Pharma K.K. | 617 Million JPY | -120118.963% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -1080.324% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | -319.395% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -1213656.709% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 49.77% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -3251.162% |